HealthWell Foundation Launches New Fund for Neuroendocrine Tumor Patients
New Fund Offers Copayment or Insurance Premium Assistance
The HealthWell Foundation, an independent non-profit charitable organization providing financial assistance to those without adequate insurance, has unveiled a new fund specifically designed to help individuals living with neuroendocrine tumors. This initiative allows eligible patients to receive up to $15,000 in assistance for copayments or insurance premiums related to essential medications aimed at treating their condition. To qualify, patients must have a household income capped at 500% of the federal poverty level.
Understanding Neuroendocrine Tumors
Neuroendocrine tumors (NETs) are classified as rare tumors that develop in neuroendocrine cells and can potentially arise anywhere in the body. Notably, these tumors are frequently found in the gastrointestinal tract, lungs, and pancreas, with the ability to spread to other areas. Diagnosing NETs poses a significant challenge as their symptoms often mimic those of other ailments, leading to potential misdiagnoses. Symptoms such as abdominal discomfort, flushing, changes in bowel habits, heart palpitations, unexplained weight fluctuations, and respiratory issues are common, making accurate diagnosis critical. Alarmingly, the rate of NET diagnoses is increasing by more than 5% each year, with approximately 175,000 individuals affected across the nation.
Personal Insights on Living with NETs
Maryann Wahmann, Executive Director of the Neuroendocrine Cancer Awareness Network (NCAN), shared her poignant perspective: "After receiving a proper diagnosis, patients often face numerous doctor appointments and follow a treatment plan involving various medications, many of which are intended for long-term use. As someone who has battled neuroendocrine cancer for more than two decades, I can personally attest to the emotional and financial struggles that accompany this condition. The costs associated with treating NETs can be prohibitive for many, and we genuinely commend HealthWell for acknowledging the financial strain on those affected and providing necessary resources to ensure continued access to proper treatment."
HealthWell Foundation's Commitment to Patients
Michael S. Heimall, President and CEO of the HealthWell Foundation, expressed enthusiasm about the new fund: "We are thrilled to include neuroendocrine tumors in our portfolio of disease funds, thus alleviating the financial burdens faced by patients living with NETs. A heartfelt thank you to our donors for supporting this essential, unmet need, enabling patients to prioritize their treatment adherence rather than the associated costs."
Eligibility and Application Process
To learn about eligibility requirements and to apply for financial support, prospective applicants can visit the HealthWell Foundation’s Neuroendocrine Tumors Fund page. It is important to note that fund openings and re-openings take place at 11:00 a.m. Eastern Daylight Time, from Monday to Friday. For additional information about HealthWell’s programs and comprehensive disease fund offerings, individuals can explore the HealthWell website.
About the Neuroendocrine Cancer Awareness Network (NCAN)
The Neuroendocrine Cancer Awareness Network (NCAN) is a dedicated non-profit organization focused on enhancing awareness for neuroendocrine cancer. They provide vital support for patients and caregivers, alongside funding for NET research initiatives. Since its inception in 2003, NCAN's mission has been to educate and uplift the NET community, striving to improve the quality of life for those affected.
About the HealthWell Foundation
The HealthWell Foundation is a nationally recognized and independently operated non-profit entity. Established in 2003, it serves as a vital resource for uninsured and underinsured patients across over 90 disease areas, impacting the lives of more than 1.1 million Americans. Throughout its history, HealthWell has disbursed over $4.8 billion in financial support through 1.8 million grants, facilitating access to crucial medical treatments that patients might otherwise forgo. Additionally, HealthWell has been commended for its outstanding fundraising efficiency and is recognized as one of America’s Top 100 Charities.
Frequently Asked Questions
What is the purpose of the new fund launched by HealthWell Foundation?
The fund aims to provide financial assistance specifically for patients living with neuroendocrine tumors, helping cover copayments and insurance premiums for necessary medications.
Who is eligible to apply for assistance from the fund?
Eligible patients must have a household income of up to 500% of the federal poverty level to qualify for the financial assistance offered by the new fund.
What are neuroendocrine tumors?
Neuroendocrine tumors are rare tumors that develop in neuroendocrine cells, often occurring in the digestive system, lungs, and pancreas, and they can present a challenge in diagnosis due to symptom overlap with other conditions.
How does one apply for assistance from the fund?
Interested applicants can visit the HealthWell Foundation’s website to determine eligibility and access the application process for assistance.
What is the overall mission of the HealthWell Foundation?
The HealthWell Foundation aims to support uninsured and underinsured patients by providing financial assistance to cover out-of-pocket medical expenses, allowing them to access necessary medical care.
